相关实验视频

Updated: Jun 6, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Ursodeoxycholic 酸治疗对Fontan相关肝病的影响

Tomomi Kogiso¹, Yuri Ogasawara², Makiko Taniai²

¹Institute of Gastroenterology, Department of Internal Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. kogiso.tomomi@twmu.ac.jp.

Journal of gastroenterology

|November 27, 2024

概括

在Fontan相关性肝病 (FALD) 患者中,乌尔索西胆酸 (UDCA) 显著降低了肝酶和肝细胞癌 (HCC) 的进展. UDCA治疗改善了生存率,可能是对FALD有益的治疗方法.

科学领域:

心脏病学心脏病学
肝病学肝病学是一种肝病学.
儿科手术儿科手术

背景情况:

芬坦相关性肝病 (FALD) 是芬坦手术后的一种进展性肝纤维化,可能导致肝细胞癌 (HCC).
目前对FALD的治疗方法有限,因此需要对新的治疗方案进行研究.
乌尔索多西胆酸 (UDCA) 在治疗FALD.在治疗FALD.在治疗FALD.在治疗FALD.在治疗FALD.

研究的目的:

评估在被诊断患有Fontan相关性肝病 (FALD) 的患者中ursodeoxycholic acid (UDCA) 的治疗疗效.
评估UDCA对肝酶水平,肝细胞癌 (HCC) 的发展以及FALD患者的整体存活率的影响.

主要方法:

在一个中心对220名FALD患者 (2003-2024) 进行了回顾性研究.
UDCA给了113名肝/胆道酶异常的患者;肝功能测试在3,6和12个月后进行监测.
卡普兰-梅尔曲线和倾向匹配分析比较了UDCA治疗和未治疗组之间的结果 (每组n=68).

主要成果:

在3个月内,UDCA显著降低了阿斯巴酸氨基转移酶 (AST),氨基转移酶 (ALT) 和马-氨基转移酶 (GGT) 的水平.
与未接受治疗组 (24.2%) 相比,UDCA组的5年HCC发病率明显较低 (5.6%).
UDCA治疗与改善的生存率和减少HCC进展有关,尽管总 bilirubin 和血小板计数没有显著变化.

结论:

在FALD患者中,乌尔索西胆酸 (UDCA) 有效降低肝酶水平,包括GGT.
UDCA治疗显示出缓解肝细胞癌 (HCC) 进展和改善生存的潜力.
对于患有Fontan相关性肝病 (FALD) 的人来说,UDCA可能是一个有益的治疗选择.

关键词:

这就是Fontan程序.丰坦相关的肝脏疾病.肝细胞癌是肝细胞癌.Ursodeoxycholic 酸是一种抗氧化的药物 .

更多相关视频

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver

Published on: June 16, 2023

相关概念视频

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: